What is known about this topic:
Global medical advances within healthcare have subsequently led to the widespread introduction of biological products such as grafts, haemostats, and sealants. Although these products have been used for many decades, this subject is frequently not discussed during the consent process and remains an area of contention.
A recent study demonstrated that in 534 patient respondents, 44% wanted to be informed if biological products were to be used and 17% objected to their use.